info:eu-repo/semantics/article
Impairment of agonist-induced M2 muscarinic receptor activation by autoantibodies from chagasic patients with cardiovascular dysautonomia
Fecha
2020-03Registro en:
Beltrame, Sabrina Paola; Carrera Paez, Laura Camila; Auger, Sergio Ricardo; Sabra, Ahmad H.; Bilder, Claudio Rubén; et al.; Impairment of agonist-induced M2 muscarinic receptor activation by autoantibodies from chagasic patients with cardiovascular dysautonomia; Academic Press Inc Elsevier Science; Clinical Immunology; 212; 3-2020; 1-9
1521-6616
CONICET Digital
CONICET
Autor
Beltrame, Sabrina Paola
Carrera Paez, Laura Camila
Auger, Sergio Ricardo
Sabra, Ahmad H.
Bilder, Claudio Rubén
Waldner, Claudia Ines
Goin, Juan Carlos
Resumen
Previous studies showed that circulating autoantibodies against M2 muscarinic receptors (anti-M2R Ab) are associated with decreased cardiac parasympathetic modulation in patients with chronic Chagas disease (CD). Here we investigated whether the exposure of M2R to such antibodies could impair agonist-induced receptor activation, leading to the inhibition of associated signaling pathways. Preincubation of M2R-expressing HEK 293T cells with serum IgG fractions from chagasic patients with cardiovascular dysautonomia, followed by the addition of carbachol, resulted in the attenuation of agonist-induced Gi protein activation and arrestin-2 recruitment. These effects were not mimicked by the corresponding Fab fractions, suggesting that they occur through receptor crosslinking. IgG autoantibodies did not enhance M2R/arrestin interaction or promote M2R internalization, suggesting that their inhibitory effects are not likely a result of short-term receptor regulation. Rather, these immunoglobulins could function as negative allosteric modulators of acetylcholine-mediated responses, thereby contributing to the development of parasympathetic dysfunction in patients with CD.